See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:DCTH

Delcath Systems Stock Predictions

etoro logo Buy DCTH
*Your capital is at risk
$10.33
-0.200 (-1.90%)
At Close: Jun 03, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 4 Jun 2026

DCTH Prediction Chart

DCTH Predictions History

Latest community submissions for DCTH.
Predictor Target Session Target Price Result Direction Accuracy Score
Vincent Vincent @Vincent.3526
Mar 3, 2017 $0.82 +455.93% Unrealistic Excluded from avg $0.150 V 0.00% 0
Matthew.Burkart.3489 Matthew.Burkart.3489
Mar 3, 2017 $0.147 -0.34% $0.150 V 99.30% 3
JS JS Pro
Feb 27, 2017 $0.160 +13.48% $0.140 V 86.50% 0
Roland.Tran.3272 Roland.Tran.3272
Feb 27, 2017 $1.07 +658.87% Unrealistic Excluded from avg $0.140 X 0.00% 0
JS JS Pro
Feb 24, 2017 $0.179 +10.97% $0.160 X 88.80% 0
JS JS Pro
Feb 23, 2017 $0.225 +32.51% $0.170 V 67.60% 0
Cameron.Hinkley.3000 Cameron.Hinkley.3000
Feb 15, 2017 $0.198 +20.00% $0.160 V 80.00% 0
JS JS Pro
Feb 15, 2017 $0.185 +12.12% $0.160 V 87.90% 0
Ron.Boutwell.1883 Ron.Boutwell.1883
Feb 15, 2017 $0.350 +112.12% Unrealistic Excluded from avg $0.160 X 0.00% 0
JS JS Pro
Jan 25, 2017 $0.546 +33.14% $0.410 X 66.80% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DCTH with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
Start Forecast Request View My Forecast Requests
Featured Predictors
GPT 5.4 Reply target 48h
Select
Gemini 3.5 Reply target 48h
Select
Opus 4.7 Reply target 48h
Select
ABOUT DELCATH SYSTEMS, INC.
Delcath Systems
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS cli...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE